Ironwood Pharmaceuticals Inc (IRWD) is looking forward to a strong quarter

With 1.83 million shares changed hands, the volume of the stock remained lighter than its average volume of 3.07 million shares. The 52-week range on IRWD shows that it touched its highest point at $15.26 and its lowest point at $1.59 during that stretch. It currently has a 1-year price target of $8.83. Beta for the stock currently stands at 0.31.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of IRWD was up-trending over the past week, with a rise of 3.19%, but this was down by -46.99% over a month. Three-month performance dropped to -52.80% while six-month performance fell -55.09%. The stock lost -87.06% in the past year, while it has lost -56.21% so far this year. A look at the trailing 12-month EPS for IRWD yields -0.02 with Next year EPS estimates of 0.17. For the next quarter, that number is 0.08. This implies an EPS growth rate of 101.20% for this year and 117.55% for next year.

Float and Shares Shorts:

At present, 160.02 million IRWD shares are outstanding with a float of 155.16 million shares on hand for trading.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for IRWD since 2 analysts follow the stock currently. There are 2 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $0.1534 being high and $0.0721864 being low. For IRWD, this leads to a yearly average estimate of $0.090233. Based on analyst estimates, the high estimate for the next quarter is $0.05 and the low estimate is -$0.02. The average estimate for the next quarter is thus $0.02.